Inventor · disambiguated record
Anja Mølhart Høg
Also filed as: HOEG ANJA MOELHART · HØG ANJA MØLHART
7 granted patents·5 pending applications·135 citations·filing 2003–2024
82Inventor score
Top patents by PatentIndex Score
12 records- 0196US7737264B2Oligomeric compounds for the modulation HIF-1α expressionENZON PHARMACEUTICALS INC·Filed 2003·Granted Jun 15, 2010·129 cites·35 claims
- 0290US11279929B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2019·Granted Mar 22, 2022·3 cites·13 claims
- 0388US2025051777A1Oligonucleotides for modulating tau expressionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0487US10799523B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Oct 13, 2020·3 cites·8 claims
- 0584US2024026360A1Oligonucleotides for modulating tau expressionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0680US12163131B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 0775US11753640B2Oligonucleotides for modulating Tau expressionHOFFMANN LA ROCHE·Filed 2020·Granted Sep 12, 2023·0 cites·8 claims
- 0870US2022143064A1Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0962US11077132B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Aug 3, 2021·0 cites·13 claims
- 1049US2010323967A1RNA Antagonist Compounds for the Modulation of MCL-1SANTARIS PHARMA AS·Filed 2008·Application pending·0 cites
- 1143US11761951B2Methods of selecting therapeutic moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 19, 2023·0 cites·19 claims
- 1239US2018023081A1Lna oligonucleotides with alternating flanksBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anja Mølhart Høg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →